Table 2.

Using GOLD COPD Groups to Select Therapy¹,^a

Group	Description	First choice	Alternative choice
A	Low symptoms, low risk	SABA or SAMA (as needed)	LAMA or LABA or SABA/SAMA
B	High symptoms, low risk	LAMA or LABA	LAMA and LABA
C	Low symptoms, high risk	ICS/LABA or LAMA	LAMA and LABA
D	High symptoms, high risk	ICS/LABA or LAMA	ICS/LABA and LAMA or ICS/LABA and PD4-inh or LAMA and LABA or LAMA and PD4-inh

^aThis table is presented for educational purposes. Any treatment decision should be weighted at the individual level. Only most common options are displayed, and the order does not indicate any preference.

Abbreviations: ICS, inhaled corticosteroids; LABA, long-acting beta agonist; LAMA, long-acting antimuscarinic; PD4-inh, phosphodiesterase-4 inhibitor; SABA, short-acting beta agonists; SAMA, short-acting antimuscarinic.